Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-51,007.17
% of Total Estimate Gain
-2.43%

Loomis Sayles Small Cap Growth Portfolio's Agios Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Brighthouse Funds Trust II held - shares of Agios Pharmaceuticals Inc(AGIO), totaling N/A. This investment constitutes 0% of their stock portfolio, and Brighthouse Funds Trust II now holds 0% of the outstanding Agios Pharmaceuticals Inc(AGIO) stock.

The initial trade took place in 2024Q2. And since then Loomis Sayles Small Cap Growth Portfolio has made 2 purchases of AGIO, at an average price of $38.41, for a total of 54,574.00 shares. In addition, there have been 2 sales at an average price of $37.47 for 54,574.00 shares. Based on historical transaction data and AGIO's current price of $40.35, Loomis Sayles Small Cap Growth Portfolio's estimated gain on his AGIO holdings is $-51,007.17, reflecting a -2.43% gain to date.

Loomis Sayles Small Cap Growth Portfolio AGIO ($40.35) Holding Chart

Loomis Sayles Small Cap Growth Portfolio AGIO ($40.35) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1